Drug recall · January 15, 2025
Ciprofloxacin Ophthalmic Solution USP recall
Why: Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05
- Lots / codes
Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025
- Quantity
- 136,181 bottles
- Company
- FDC Limited, Aurangabad, Maharashtra State
- Distribution
- Nationwide
- Initiated
- December 16, 2024 · Voluntary: Firm initiated
- Classified
- January 3, 2025
- Reported
- January 15, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ciprofloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.